[go: up one dir, main page]

NO161741C - Analogifremgangsm te ved fremstilling av pyrrolo(1,2-a)imidazoler eller imidazo(1,2-a)pyridiner. - Google Patents

Analogifremgangsm te ved fremstilling av pyrrolo(1,2-a)imidazoler eller imidazo(1,2-a)pyridiner.

Info

Publication number
NO161741C
NO161741C NO843053A NO843053A NO161741C NO 161741 C NO161741 C NO 161741C NO 843053 A NO843053 A NO 843053A NO 843053 A NO843053 A NO 843053A NO 161741 C NO161741 C NO 161741C
Authority
NO
Norway
Prior art keywords
imidazo
pyrrolo
pyridines
imidazoles
preparation
Prior art date
Application number
NO843053A
Other languages
English (en)
Other versions
NO843053L (no
NO161741B (no
Inventor
Thomas A Davidson
Robert J Murray
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO843053L publication Critical patent/NO843053L/no
Publication of NO161741B publication Critical patent/NO161741B/no
Publication of NO161741C publication Critical patent/NO161741C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO843053A 1983-07-29 1984-07-27 Analogifremgangsm te ved fremstilling av pyrrolo(1,2-a)imidazoler eller imidazo(1,2-a)pyridiner. NO161741C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/518,514 US4507481A (en) 1983-07-29 1983-07-29 Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines

Publications (3)

Publication Number Publication Date
NO843053L NO843053L (no) 1985-01-30
NO161741B NO161741B (no) 1989-06-12
NO161741C true NO161741C (no) 1989-09-20

Family

ID=24064258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843053A NO161741C (no) 1983-07-29 1984-07-27 Analogifremgangsm te ved fremstilling av pyrrolo(1,2-a)imidazoler eller imidazo(1,2-a)pyridiner.

Country Status (15)

Country Link
US (1) US4507481A (no)
EP (1) EP0150255B1 (no)
JP (1) JPS6042384A (no)
KR (1) KR910002837B1 (no)
AT (1) ATE59042T1 (no)
AU (1) AU562722B2 (no)
CA (1) CA1250295A (no)
DE (1) DE3483745D1 (no)
DK (1) DK367084A (no)
FI (1) FI78090C (no)
IL (1) IL71943A (no)
NO (1) NO161741C (no)
NZ (1) NZ208266A (no)
PH (1) PH19437A (no)
ZA (1) ZA844299B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4551535A (en) * 1983-07-29 1985-11-05 Pennwalt Corporation Process for preparing novel 7-thioester derivatives of 3H pyrrolo [1,2-a]-imidazole and 8-thioester derivatives of imidazo [1,2-a] pyridine
US4670445A (en) * 1984-03-05 1987-06-02 Eli Lilly And Company Inotropic agents
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
KR930703321A (ko) * 1990-12-13 1993-11-29 스튜어트 알. 슈터 신규한 사이토킨 억제성 소염 의약
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
CA2134009C (en) * 1993-11-11 2005-03-08 Oleg Werbitzky Bicyclic amidines, process for their preparation, and their use as catalyst
AU2682695A (en) * 1994-06-20 1996-01-15 Takeda Chemical Industries Ltd. Condensed imidazole compounds, their production and use
WO2016183266A1 (en) 2015-05-13 2016-11-17 Enanta Pharmaceuticals, Inc. Ehpatitis b antiviral agents
US10179131B2 (en) 2015-07-13 2019-01-15 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US10280175B2 (en) 2016-02-02 2019-05-07 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
EP3426245B1 (en) 2016-03-07 2022-12-14 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
MX2018015315A (es) 2016-06-10 2019-04-25 Enanta Pharm Inc Agentes antivirales contra la hepatitis b.
KR102556744B1 (ko) 2017-08-28 2023-07-18 이난타 파마슈티칼스, 인코포레이티드 B형 간염 항바이러스제
US10723733B2 (en) 2017-12-06 2020-07-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2019113173A1 (en) 2017-12-06 2019-06-13 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
WO2019143902A2 (en) 2018-01-22 2019-07-25 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2019191166A1 (en) 2018-03-29 2019-10-03 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
CA3113235A1 (en) 2018-09-21 2020-03-26 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2020106816A1 (en) 2018-11-21 2020-05-28 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2020247444A1 (en) 2019-06-03 2020-12-10 Enanta Pharmaceuticals, Inc, Hepatitis b antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2021007488A1 (en) 2019-07-11 2021-01-14 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984665A (en) * 1958-05-14 1961-05-16 Rohm & Haas Condensed heterocyclic compounds
US4126685A (en) * 1975-01-31 1978-11-21 Imperial Chemical Industries Limited 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0150255B1 (en) 1990-12-12
EP0150255A2 (en) 1985-08-07
FI843001A (fi) 1985-01-30
US4507481A (en) 1985-03-26
ATE59042T1 (de) 1990-12-15
PH19437A (en) 1986-04-15
DE3483745D1 (de) 1991-01-24
FI843001A0 (fi) 1984-07-27
IL71943A0 (en) 1984-09-30
NO843053L (no) 1985-01-30
NZ208266A (en) 1987-03-31
AU562722B2 (en) 1987-06-18
JPS6042384A (ja) 1985-03-06
CA1250295A (en) 1989-02-21
IL71943A (en) 1987-07-31
AU2885284A (en) 1985-01-31
EP0150255A3 (en) 1988-01-07
KR850001210A (ko) 1985-03-16
FI78090B (fi) 1989-02-28
ZA844299B (en) 1985-01-30
NO161741B (no) 1989-06-12
KR910002837B1 (ko) 1991-05-06
DK367084A (da) 1985-01-30
FI78090C (fi) 1989-06-12
DK367084D0 (da) 1984-07-27

Similar Documents

Publication Publication Date Title
NO161741C (no) Analogifremgangsm te ved fremstilling av pyrrolo(1,2-a)imidazoler eller imidazo(1,2-a)pyridiner.
AU4506489A (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
NO810198L (no) Fremgangsmaate ved fremstilling av imidazo (1,2-a)pyridiner.
ZA877085B (en) 2-or 3-aryl substituted imidazo(1,2-a)pyridines
PH17158A (en) Imidazo(1,2-a)pyridin-2-yl carbostyril derivatives and compositions containing same
AU7849387A (en) 2- or-3- aryl substituted imidazo(1,2-a)pyridines
NO171914C (no) Analogifremgangsmaate ved fremstilling av tricykliske pyridinderivate
AU516695B2 (en) Heterocyclic substituted imidazo (1, 2-a)pyridines
NO930276D0 (no) Fremgangsmaate for fremstilling av imidazo(4,5-b)pyridin-derivater
MY103766A (en) Pyrrolo[1,2-a]imidazole and imidazo[1,2-a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
NO840969L (no) Pyrazolo(1,5-a)pyridinderivater, fremgangsmaate ved fremstilling av dem og blandinger som inneholder dem
NO842014L (no) Fremgangsmaate til fremstilling av beta-karbolin-3-karboksylsyrederivater
NO801376L (no) Fremgangsmaate ved fremstilling av 3-substituerte tetrahydro-pyrrolo(1,2-a)pyrimidinderivater
NO176103C (no) Analogifremgangsmåte for fremstilling av mitomycinfosfatderivat
AU5771780A (en) 3-substituted imidazo (1,2-a) pyridines
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
AU572237B2 (en) Imidazoline substituted pyrrolo (3,2,1-hi) indole derivatives
AU548784B2 (en) Imidazo(1,2-a)imidazole derivatives
AU621308C (en) Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
ZA886511B (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
CS397691A3 (en) Pyrrolo(1,2-a)imidazole and pyrrolo(1,2-a)pyridine derivatives and theiruse as 5-lipoxygenase pathway inhibitors